| Targeted drug delivery to macrophages NK Jain, V Mishra, NK Mehra Expert opinion on drug delivery 10 (3), 353-367, 2013 | 208 | 2013 |
| A review of ligand tethered surface engineered carbon nanotubes NK Mehra, V Mishra, NK Jain Biomaterials 35 (4), 1267-1283, 2014 | 200 | 2014 |
| A review on comparative study of PPI and PAMAM dendrimers D Kaur, K Jain, NK Mehra, P Kesharwani, NK Jain Journal of Nanoparticle Research 18, 1-14, 2016 | 151 | 2016 |
| Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential N Mody, RK Tekade, NK Mehra, P Chopdey, NK Jain Aaps Pharmscitech 15, 388-399, 2014 | 140 | 2014 |
| Role of antioxidants for the treatment of cardiovascular diseases: challenges and opportunities A K Jain, N K Mehra, N K Swarnakar Current pharmaceutical design 21 (30), 4441-4455, 2015 | 137 | 2015 |
| Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers J Singh, K Jain, NK Mehra, NK Jain Artificial cells, nanomedicine, and biotechnology 44 (7), 1626-1634, 2016 | 118 | 2016 |
| Biomedical applications of carbon nanotubes: a critical review P Sharma, N Kumar Mehra, K Jain, NK Jain Current drug delivery 13 (6), 796-817, 2016 | 112 | 2016 |
| Pharmaceutical and biomedical applications of surface engineered carbon nanotubes NK Mehra, K Jain, NK Jain Drug Discovery Today 20 (6), 750-759, 2015 | 109 | 2015 |
| COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic V Bhavana, P Thakor, SB Singh, NK Mehra Life sciences 261, 118336, 2020 | 102 | 2020 |
| Pharmaceutical and biomedical applications of quantum dots N Bajwa, NK Mehra, K Jain, NK Jain Artificial cells, nanomedicine, and biotechnology 44 (3), 758-768, 2016 | 96 | 2016 |
| Hyperbranched dendritic nano-carriers for topical delivery of dithranol U Agrawal, NK Mehra, U Gupta, NK Jain Journal of drug targeting 21 (5), 497-506, 2013 | 96 | 2013 |
| Carbon nanotubes and their toxicity AK Jain, N Kumar Mehra, N Lodhi, V Dubey, DK Mishra, PK Jain, NK Jain Nanotoxicology 1 (3), 167-197, 2007 | 96 | 2007 |
| Receptor-based targeting of therapeutics NK Mehra, V Mishra, NK Jain Therapeutic delivery 4 (3), 369-394, 2013 | 95 | 2013 |
| Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization AK Jain, V Dubey, NK Mehra, N Lodhi, M Nahar, DK Mishra, NK Jain Nanomedicine: Nanotechnology, Biology and Medicine 5 (4), 432-442, 2009 | 95 | 2009 |
| Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity R Singh, P Kesharwani, NK Mehra, S Singh, S Banerjee, NK Jain Drug development and industrial pharmacy 41 (11), 1888-1901, 2015 | 93 | 2015 |
| Interactions between carbon nanotubes and bioactives: a drug delivery perspective NK Mehra, S Palakurthi Drug Discovery Today 21 (4), 585-597, 2016 | 92 | 2016 |
| Potentials and emerging trends in nanopharmacology K Jain, NK Mehra, NK Jain Current opinion in pharmacology 15, 97-106, 2014 | 88 | 2014 |
| Challenges in the use of carbon nanotubes for biomedical applications NK Mehra, AK Jain, N Lodhi, R Raj, V Dubey, D Mishra, M Nahar, NK Jain Critical Reviews™ in Therapeutic Drug Carrier Systems 25 (2), 2008 | 82 | 2008 |
| Glycyrrhizin conjugated dendrimer and multi-walled carbon nanotubes for liver specific delivery of doxorubicin PK Chopdey, RK Tekade, NK Mehra, N Mody, NK Jain Journal of nanoscience and nanotechnology 15 (2), 1088-1100, 2015 | 77 | 2015 |
| Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes J Pruthi, NK Mehra, NK Jain Journal of drug targeting 20 (7), 593-604, 2012 | 77 | 2012 |
Dr. Keerti JainNational Institute of Pharmaceutical Education and Research - Raebareli (NIPER-R), Lucknow, IndiaBestätigte E-Mail-Adresse bei niperraebareli.edu.in
